SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+5.57%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$277M
AUM Growth
+$277M
(-7%)
Cap. Flow
-$31.4M
Cap. Flow
% of AUM
-11.32%
Top 10 Holdings %
Top 10 Hldgs %
84.21%
Holding
28
New
6
Increased
8
Reduced
7
Closed
7
Top Buys
| 1 |
Evolus
EOLS
|
$28.6M |
| 2 |
QuidelOrtho
QDEL
|
$28.2M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
$24.2M |
| 4 |
X4 Pharmaceuticals
XFOR
|
$8.93M |
| 5 |
SCYNEXIS
SCYX
|
$7.36M |
Top Sells
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$91.5M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$27.4M |
| 3 |
Xeris Biopharma Holdings
XERS
|
$8.23M |
| 4 |
Dynavax Technologies
DVAX
|
$4.09M |
| 5 |
Galapagos
GLPG
|
$4.05M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
QuidelOrtho
QDEL
$1.95B
| $51.3M | 18.51% | 619,426 +340,345 | +122% | +$28.2M |
|
|
2
Evolus
EOLS
$494M
| $32.8M | 11.82% | 4,506,197 +3,927,402 | +679% | +$28.6M |
|
3
ADMA Biologics
ADMA
$4.12B
| $32.4M | 11.7% | 8,793,321 +1,131,631 | +15% | +$4.18M |
|
|
4
Galapagos
GLPG
$2.07B
| $27.8M | 10.01% | 682,664 -99,625 | -13% | -$4.05M |
|
|
5
Amylyx Pharmaceuticals
AMLX
$836M
| $24.2M | 8.72% | +1,121,028 | New | +$24.2M |
|
6
MaxCyte
MXCT
$148M
| $18.2M | 6.57% | 3,966,916 +1,259,826 | +47% | +$5.78M |
|
|
7
Xeris Biopharma Holdings
XERS
$1.26B
| $14.4M | 5.2% | 5,500,228 -3,139,977 | -36% | -$8.23M |
|
|
THRD
8
DELISTED
Third Harmonic Bio
THRD
| $13.4M | 4.85% | 2,793,149 -338,846 | -11% | -$1.63M |
|
|
ATYR
9
aTyr Pharma
ATYR
$527M
| $9.99M | 3.61% | 4,627,224 -198,498 | -4% | -$429K |
|
|
10
X4 Pharmaceuticals
XFOR
$84.2M
| $8.93M | 3.22% | +4,605,263 | New | +$8.93M |
|
|
11
SCYNEXIS
SCYX
$34.9M
| $8.69M | 3.14% | 2,946,346 +2,496,346 | +555% | +$7.36M |
|
12
Xoma
XOMA
$392M
| $6.6M | 2.38% | 349,399 +31,303 | +10% | +$591K |
|
13
Rezolute
RZLT
$619M
| $6.08M | 2.19% | 3,072,476 -15,173 | -0.5% | -$30K |
|
14
TELA Bio
TELA
$70.5M
| $4.89M | 1.76% | +482,619 | New | +$4.89M |
|
15
UroGen Pharma
URGN
$900M
| $4.64M | 1.67% | 448,508 -253,027 | -36% | -$2.62M |
|
16
Exagen
XGN
$217M
| $3.04M | 1.1% | 1,049,352 +12,278 | +1% | +$35.6K |
|
|
GMDA
17
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $2.9M | 1.04% | +1,500,000 | New | +$2.9M |
|
18
Atea Pharmaceuticals
AVIR
$267M
| $2.81M | 1.01% | 752,088 +67,580 | +10% | +$253K |
|
19
Delcath Systems
DCTH
$385M
| $2.1M | 0.76% | +378,787 | New | +$2.1M |
|
20
Castle Biosciences
CSTL
$696M
| $1.26M | 0.46% | 91,978 -200,888 | -69% | -$2.76M |
|
21
AYTU BioPharma
AYTU
$21.1M
| $756K | 0.27% | +472,369 | New | +$756K |
|
22
Cidara Therapeutics
CDTX
$1.66B
| – | – | -1,000 | Closed | -$1.27K |
|
|
23
Dynavax Technologies
DVAX
$1.19B
| – | – | -416,519 | Closed | -$4.09M |
|
24
Travere Therapeutics
TVTX
$1.56B
| – | – | -132,005 | Closed | -$2.97M |
|
|
AMYT
25
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| – | – | -6,278,085 | Closed | -$91.5M |
|